Tamoxifen Tablets (Generic Nolvadex)
Tamoxifen citrate—widely recognized under the reference brand name Nolvadex—is an orally active selective estrogen receptor modulator (SERM) essential to clinical oncology, sports endocrinology, and post-cycle hormone restoration. Engineered with tissue-specific estrogen receptor agonism and antagonism, tamoxifen selectively blocks estrogenic activity within breast and glandular tissue while promoting gonadotropin release to re-establish endogenous testosterone production.
Our verified catalog features authentic pharmaceutical-grade tamoxifen citrate tablets manufactured under stringent quality protocols, ensuring uniform active substance dispersion, dependable dissolution rates, and certified chemical purity.
Mechanism of Action & Pharmacological Profile
The pharmacodynamics of tamoxifen citrate involve competitive antagonism at targeted estrogen receptor (ER) sites. Unlike aromatase inhibitors, which halt the systemic production of estrogens by inactivating the aromatase enzyme, tamoxifen allows circulating estradiol to remain present while physically occupying receptor sites to prevent cellular transcription:
- Mammary Tissue Blockade: Exhibits powerful anti-estrogenic antagonism in breast tissue, preventing and reversing early-stage glandular tissue development (gynecomastia) triggered by aromatizing compounds.
- Hypothalamic-Pituitary Disinhibition: Blocks estrogen negative feedback at the hypothalamus and pituitary gland, triggering pulsatile secretion of gonadotropin-releasing hormone (GnRH) and stimulating luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release.
- Hepatic Estrogen Agonism: Functions as a partial agonist in liver tissue, supporting healthy hepatic transcription pathways that favorably influence lipid profiles (often elevating HDL and lowering LDL concentrations).
Technical Specifications & Administration Protocols
Tamoxifen is formulated in scored oral tablets designed for precise dose administration. Due to the extended clearance kinetics of its primary active metabolites (such as endoxifen and 4-hydroxytamoxifen), the drug exhibits a terminal elimination half-life of 5 to 7 days, allowing once-daily administration to sustain steady serum levels.
| Specification | Standard Post Cycle Protocol (PCT) | Acute Gynecomastia Intervention |
|---|---|---|
| Formulation Type | Oral scored tablets | Oral scored tablets |
| Administration Frequency | Once daily (consistent timing) | Once daily (acute phase) |
| Protocol Duration | 4–6 weeks | 2–4 weeks (until symptoms resolve) |
| Primary Focus | Endocrine restart & tissue retention | Receptor blockade in glandular tissue |
| Active Half-Life | Approx. 5–7 days | Approx. 5–7 days |
Primary Applications in Performance Regimens
- Post Cycle Recovery (PCT): Serves as a foundational SERM immediately following the clearance of suppressive anabolic steroids to stimulate Leydig cell output and restore natural endocrine balance.
- Targeted Gynecomastia Prevention: Deployed on-cycle at the earliest signs of nipple tenderness, puffiness, or sensitivity to neutralize local estrogenic activation without altering systemic estradiol levels.
- Cardiovascular Lipid Support: Helps counteract the negative lipid alterations induced by non-aromatizing and oral steroids by promoting favorable lipid metabolism through hepatic estrogen receptor agonism.
Safety Profile & Protocol Guidelines
While tamoxifen demonstrates an established clinical safety track record across decades of therapeutic use, adhering to structured protocol guidelines helps prevent adverse reactions:
- Avoidance with Progestogenic Compounds: Tamoxifen may upregulate progesterone receptors in certain tissues. When managing gynecomastia or recovering from 19-nor steroids (such as Trenbolone or Nandrolone), combine with prolactin antagonists rather than escalating SERM doses alone.
- Thromboembolic Vigilance: As with all SERMs, prolonged administration can slightly influence clotting factors. Ensure adequate hydration, routine cardiovascular activity, and avoid concurrent smoking.
- Endocrine Follow-Up: Conducting a full hormonal panel (measuring total testosterone, free testosterone, sensitive estradiol, and LH/FSH) 3 to 4 weeks after protocol completion ensures the endocrine axis has stabilized.
Quality Certification & Order Fulfillment
- HPLC Lab Certified: All tablet batches undergo independent liquid chromatography testing to guarantee active compound potency, exact formulation integrity, and total absence of harmful impurities.
- Discreet & Neutral Packaging: Blister packs and bottles are shipped in unmarked, tamper-evident protective mailers with no visible labels to maintain total recipient privacy.
- Tracked Global Transit: Reliable dispatch accompanied by real-time end-to-end parcel tracking provides continuous transparency from fulfillment directly to your destination.